TY - JOUR
T1 - Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients
AU - Dentone, Chiara
AU - Di Biagio, Antonio
AU - Parodi, Alessia
AU - Bozzano, Federica
AU - Fraccaro, Paolo
AU - Signori, Alessio
AU - Cenderello, Giovanni
AU - Mantia, Eugenio
AU - Orofino, Giancarlo
AU - De Maria, Andrea
AU - Filaci, Gilberto
AU - Fenoglio, Daniela
PY - 2014/4/24
Y1 - 2014/4/24
N2 - This is a cross-sectional, case-control study analyzing the effect of antiretroviral therapy (ART) including or not maraviroc, on circulating monocytes and natural killer cells. Sixty-eight HIV-positive patients virologically suppressed receiving ART at least 6 months were subdivided as receiving (group 1) or not (group 2) maraviroc in their ART. Frequency of monocytes and natural killer cells, as well as their activation markers, were studied. Modulation of innate immune cells may be differently affected by combined ART.
AB - This is a cross-sectional, case-control study analyzing the effect of antiretroviral therapy (ART) including or not maraviroc, on circulating monocytes and natural killer cells. Sixty-eight HIV-positive patients virologically suppressed receiving ART at least 6 months were subdivided as receiving (group 1) or not (group 2) maraviroc in their ART. Frequency of monocytes and natural killer cells, as well as their activation markers, were studied. Modulation of innate immune cells may be differently affected by combined ART.
UR - http://www.scopus.com/inward/record.url?scp=84897490401&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84897490401&partnerID=8YFLogxK
U2 - 10.1097/QAD.0000000000000194
DO - 10.1097/QAD.0000000000000194
M3 - Article
C2 - 24499952
AN - SCOPUS:84897490401
VL - 28
SP - 1071
EP - 1074
JO - AIDS
JF - AIDS
SN - 0269-9370
IS - 7
ER -